Back to LLY
FOSTER DYKEMA CABOT & PARTNERS, LLC → LLY
FOSTER DYKEMA CABOT & PARTNERS, LLC LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
5
Latest value
$32.1M
Q3 2026
Peak value
$33.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $22.9M |
| Q4 2025 | $30.2M |
| Q1 2026 | $25.8M |
| Q2 2026 | $33.6M |
| Q3 2026 | $32.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $32.1M | 27.8K | — | — |
| Q2 2026 | $33.6M | 28.0K | — | — |
| Q1 2026 | $25.8M | 28.1K | — | — |
| Q4 2025 | $30.2M | 28.1K | — | — |
| Q3 2025 | $22.9M | 30.1K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B
$62.3B
$59.7B